Goudevenos JA - Search Results

1

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD. Tsimihodimos V, et al. Among authors: goudevenos ja. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):306-11. doi: 10.1161/hq0202.102918. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834533 Clinical Trial.

2

Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease.

Tsironis LD, Katsouras CS, Lourida ES, Mitsios JV, Goudevenos J, Elisaf M, Tselepis AD. Tsironis LD, et al. Atherosclerosis. 2004 Nov;177(1):193-201. doi: 10.1016/j.atherosclerosis.2004.07.030. Atherosclerosis. 2004. PMID: 15488884

3

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Tsimihodimos V, et al. Among authors: goudevenos ja. J Lipid Res. 2002 Feb;43(2):256-63. J Lipid Res. 2002. PMID: 11861667 Free article.

4

The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.

Mitsios JV, Papathanasiou AI, Elisaf M, Goudevenos JA, Tselepis AD. Mitsios JV, et al. Among authors: goudevenos ja. Platelets. 2005 Aug;16(5):287-92. doi: 10.1080/09537100400028776. Platelets. 2005. PMID: 16011979 Free article.

5

The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.

Lourida ES, Papathanasiou AI, Goudevenos JA, Tselepis AD. Lourida ES, et al. Among authors: goudevenos ja. Prostaglandins Leukot Essent Fatty Acids. 2006 Aug;75(2):117-26. doi: 10.1016/j.plefa.2006.03.012. Epub 2006 Jul 14. Prostaglandins Leukot Essent Fatty Acids. 2006. PMID: 16843649

6

Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment.

Papathanasiou AI, Lourida ES, Tsironis LD, Goudevenos JA, Tselepis AD. Papathanasiou AI, et al. Among authors: goudevenos ja. Atherosclerosis. 2008 Jan;196(1):289-297. doi: 10.1016/j.atherosclerosis.2006.10.033. Epub 2006 Nov 30. Atherosclerosis. 2008. PMID: 17140582 Clinical Trial.

7

Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions.

Karabina SA, Liapikos TA, Grekas G, Goudevenos J, Tselepis AD. Karabina SA, et al. Biochim Biophys Acta. 1994 Jun 23;1213(1):34-8. doi: 10.1016/0005-2760(94)90219-4. Biochim Biophys Acta. 1994. PMID: 8011677

8

PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.

Karabina SA, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD. Karabina SA, et al. Atherosclerosis. 1996 Aug 23;125(1):121-34. doi: 10.1016/0021-9150(96)05872-8. Atherosclerosis. 1996. PMID: 8831934

9

Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty.

Goudevenos J, Tselepis AD, Vini MP, Michalis L, Tsoukatos DC, Elisaf M, Ninio E, Sideris DA. Goudevenos J, et al. Eur J Clin Invest. 2001 Jan;31(1):15-23. doi: 10.1046/j.1365-2362.2001.00782.x. Eur J Clin Invest. 2001. PMID: 11168434

10

Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.

Tselepis AD, Goudevenos JA, Tambaki AP, Michalis L, Stroumbis CS, Tsoukatos DC, Elisaf M, Sideris DA. Tselepis AD, et al. Among authors: goudevenos ja. Cardiovasc Res. 1999 Jul;43(1):183-91. doi: 10.1016/s0008-6363(99)00078-4. Cardiovasc Res. 1999. PMID: 10536703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters